Acadia Healthcare Company, Inc. (ACHC) Stock Forecast & Price Target

Acadia Healthcare Company, Inc. (ACHC) has an ST Score of 53.7 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Analysts rate ACHC a Buy, with a price target of $34.78 (+10.7% vs the current price). Our ST Score grades it B- (53.7/100). The ST Score is a data-driven signal, not a recommendation.

Valuation A-, Profitability C-, Financial Strength C, Momentum A-, Growth C-, Forecast B+.

Acadia Healthcare Company, Inc. (ACHC) earns a valuation grade of A-, measured against Medical - Care Facilities peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

Acadia Healthcare Company, Inc. (ACHC) earns a growth grade of C-, measured against Medical - Care Facilities peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

Acadia Healthcare Company, Inc. (ACHC) earns a profitability grade of C-, measured against Medical - Care Facilities peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

Acadia Healthcare Company, Inc. (ACHC) earns a financial strength grade of C, measured against Medical - Care Facilities peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

The average analyst price target for Acadia Healthcare Company, Inc. (ACHC) is $34.78 from 25 analysts, which is +10.7% versus the recent price of $31.43.

Acadia Healthcare Company, Inc. (ACHC) has a Piotroski F-Score of 4 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.